Organogenesis Holdings Inc. (ORGO) Payments Of Deferred Acquisition Consideration — Quarterly & Annual

Screener

Payments Of Deferred Acquisition Consideration at other companies

Digital TurbineAPPS

$0-100%

Ziff DavisZD

$1.13M+183%

Cardinal Infrastructure Group, Inc.CDNL

$3.77M—

Veritone, Inc.VERI

-$4K—

Cineverse Corp.CNVS

$464K+95.0%

Cineverse Corp.CNVS

$464K+95.0%

Other financials

Income statement

Revenue$43.8M-56.7%

Gross profit$63.0M-22.5%

Operating income-$51.0M-305%

Net income-$96.3M-925%

EPS (diluted)-$0.77-670%

Balance sheet

Cash & equivalents$46.1M-36.9%

Total debt$36.6M+19.2%

Total equity$148.3M-36.4%

Total assets$406.4M-11.9%

Cash flow

Operating cash flow-$31.7M+3.7%

CapEx$1.1M-69.8%

Free cash flow-$32.8M+10.3%

Valuation

Market cap$310.11M-45.7%

Enterprise value$300.57M-43.1%

P/S0.7×-0.7×

Profitability

Gross margin75.9%+0.8pp

Operating margin-7.8%—

Net margin-18.4%-20.8pp

FCF margin6.9%—

Returns & leverage

Return on equity-44.1%-48.0pp

Debt / equity0.2×+0.1×

Current ratio3.5×-0.4×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept orgo:PaymentsOfDeferredAcquisitionConsideration.

The source filing: Organogenesis Holdings Inc.’s 10-K, filed February 27, 2025. Open the filing →

Filed: Feb 27, 2025
Fiscal year: FY2024
Accession: 0000950170-25-029137

FAQ

What is Organogenesis Holdings Inc.'s payments of deferred acquisition consideration?: Organogenesis Holdings Inc. (ORGO) reported payments of deferred acquisition consideration of $0 in Q4 2024.
What does payments of deferred acquisition consideration mean?: Payments Of Deferred Acquisition Consideration as reported by Organogenesis Holdings Inc. Class A Common Stock.

Ask your AI about Organogenesis Holdings Inc.'s payments of deferred acquisition consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk